Very recently, a number of papers on these concepts have appeared [9, 33 48].
This is an interesting and informative paper on the concept of PAINS (pan-assay interference compounds), compounds that have apparent activity in multiple assays, but in fact produce false signals due to non-specific interactions or interference with the assays.
On paper, this concept seems improbable as the premise for a comedy series.
He has submitted a paper on the concept he calls "Bright Water" to the journal Climatic Change.
Fujitsu is considering turning this into a working product for inclusion on some of its tablets and smartphones and has been at it for a while now — company researchers published a paper on the concept back in 2011.
The first use of the term "methodological individualism" in English was again by Schumpeter in his 1909 Quarterly Journal of Economics paper, "On the Concept of Social Value" (see Udehn 2001, 214).
Also, while we focus in the paper on the concept of clinical heterogeneity, many of these recommendations apply to investigating other sources of heterogeneity (e.g., methodological heterogeneity).
The models presented in this paper are also based on this concept.
Following on this concept, some papers have been published showing that ExMVs act as signaling device and activate target cells by ligands expressed on the ExMV surface [10, 11] or by the transfer of membrane receptors from one cell to another [12].
In this paper, we propose a method based on this concept.
